Table 1 Physical characteristics of participants
SE trial | LE trial | |
|---|---|---|
Age (years) | 22.1 ± 1.6 (19–24) | |
Height (cm) | 174.8 ± 5.8 (162.3–181.2) | |
Weight (kg) | 68.7 ± 5.2 (60.5–77.1) | 68.6 ± 4.8 (60.9–77.2) |
BMI (kg/m2) | 22.5 ± 1.0 (20.6–24.0) | 22.4 ± 1.0 (20.1–24.1) |
Body composition | ||
%Fat (%) | 14.9 ± 3.6 (10.3–21.1) | 14.7 ± 3.8 (9.8–21.2) |
Fat mass (kg) | 10.2 ± 2.5 (6.9–13.7) | 10.1 ± 2.7 (6.4–14.3) |
Skeletal muscle mass (kg) | 55.3 ± 4.8 (48.4–63.6) | 55.3 ± 4.6 (48.8–62.9) |
Blood pressure | ||
Systolic blood pressure (mmHg) | 107.1 ± 8.7 (91–117) | 107.0 ± 9.3 (92–122) |
Diastolic blood pressure (mmHg) | 63.9 ± 7.2 (49–74) | 64.0 ± 9.5 (52–73) |
Health-related blood parameters | ||
TC (mg/dL) | 160.0 ± 26.5 (123–212) | 156.9 ± 22.8 (122–191) |
TG (mg/dL) | 76.3 ± 16.8 (50–102) | 77.4 ± 14.4 (54–93) |
HDLC (mg/dL) | 54.8 ± 11.6 (36–77) | 54.2 ± 10.0 (38–76) |
LDLC (mg/dL) | 89.6 ± 21.1 (52–121) | 87.3 ± 16.0 (55–120) |
Hemoglobin A1C (%) | 5.2 ± 0.2 (4.8–5.5) | 5.2 ± 0.2 (4.7–5.7) |
Creatinine (mg/dL) | 0.89 ± 0.11 (0.72–1.09) | 0.92 ± 0.14 (0.63–1.18) |
eGFR (mL/min/1.73 m2) | 92.1 ± 14.0 (72.7–116.0) | 89.9 ± 16.8 (66.7–134.2) |
Aerobic capacity | ||
Maximal HR (beat/min) | 188.8 ± 6.8 (178–201) | |
Maximal load (watts) | 235.0 ± 24.2 (195–270) | |
VO2peak (ml/kg/min) | 44.7 ± 5.5 (35.7–54.8) | |
VO2peak (ml/min) | 3097.2 ± 370 (2661–3720) | |
Physical activity | ||
MPA (min/week) | 90 (0–600) | |
VPA (min/week) | 90 (0–180) | |